Genetic testing by cancer site: skin

Area of Science:

• Oncology
• Dermatology
• Genetics

Background:

• Hereditary cancer predisposition syndromes often manifest with distinct cutaneous findings.
• Dermatological examination and histopathology are crucial for diagnosing these syndromes when integrated with patient history.
• Skin manifestations serve as key indicators for various cancer syndromes.

Purpose of the Study:

• To review the phenotype, medical management, and genetic testing for four specific hereditary cancer syndromes with cutaneous findings.
• To highlight the diagnostic significance of dermatological signs in hereditary cancer syndromes.
• To provide a comprehensive overview for clinicians managing patients at risk for these conditions.

Main Methods:

• Literature review focusing on hereditary cancer syndromes with cutaneous manifestations.
• Analysis of clinical phenotypes, diagnostic criteria, and management strategies.
• Summary of genetic testing approaches for hereditary cancer syndromes.

Main Results:

• Cutaneous findings are integral to the diagnosis of syndromes like Cowden syndrome and Birt-Hogg-Dubé.
• This article specifically details hereditary melanoma, basal cell nevus syndrome, neurofibromatosis type 1, and neurofibromatosis type 2.
• Phenotypic characteristics, management protocols, and genetic testing options are outlined for each syndrome.

Conclusions:

• Dermatological assessment is a vital component in the early detection and diagnosis of hereditary cancer predisposition.
• Understanding the specific cutaneous findings associated with syndromes like neurofibromatosis is essential for timely intervention.
• Integrated genetic and clinical approaches are necessary for comprehensive management of hereditary cancer syndromes.